MR imaging helps predict time from symptom onset in patients with acute stroke: implications for patients with unknown onset time.

PubWeight™: 1.31‹?› | Rank: Top 10%

🔗 View Article (PMID 21045177)

Published in Radiology on November 02, 2010

Authors

Mina Petkova1, Sebastian Rodrigo, Catherine Lamy, Georges Oppenheim, Emmanuel Touzé, Jean-Louis Mas, Jean-François Méder, Catherine Oppenheim

Author Affiliations

1: Department of Radiology, Université Paris Descartes, INSERM U894, Centre Hospitalier Sainte-Anne, 1 rue Cabanis, 75014 Paris, France.

Articles citing this

Quantitative measurements of relative fluid-attenuated inversion recovery (FLAIR) signal intensities in acute stroke for the prediction of time from symptom onset. J Cereb Blood Flow Metab (2012) 1.03

Wake-up stroke and stroke of unknown onset: a critical review. Front Neurol (2014) 0.98

Diffusion-weighted imaging-fluid attenuated inversion recovery mismatch in nocturnal stroke patients with unknown time of onset. J Stroke Cerebrovasc Dis (2012) 0.93

T2* "susceptibility vessel sign" demonstrates clot location and length in acute ischemic stroke. PLoS One (2013) 0.90

Imaging stroke patients with unclear onset times. Neuroimaging Clin N Am (2011) 0.90

Wake-up stroke: clinical characteristics, imaging findings, and treatment option - an update. Front Neurol (2014) 0.88

A pragmatic approach using magnetic resonance imaging to treat ischemic strokes of unknown onset time in a thrombolytic trial. Stroke (2012) 0.85

Comparative study of the relative signal intensity on DWI, FLAIR, and T2 images in identifying the onset time of stroke in an embolic canine model. Neurol Sci (2014) 0.84

THrombolysis for Acute Wake-up and unclear-onset Strokes with alteplase at 0·6 mg/kg (THAWS) Trial. Int J Stroke (2014) 0.84

Judgment of FLAIR signal change in DWI-FLAIR mismatch determination is a challenge to clinicians. J Neurol (2011) 0.83

Negative fluid-attenuated inversion recovery-based intravenous thrombolysis using recombinant tissue plasminogen activator in acute stroke patients with unknown onset time. Cerebrovasc Dis Extra (2013) 0.83

Blood glutathione S-transferase-π as a time indicator of stroke onset. PLoS One (2012) 0.81

MRI-guided selection of patients for treatment of acute ischemic stroke. Curr Opin Neurol (2014) 0.80

What to do With Wake-Up Stroke. Neurohospitalist (2015) 0.78

Association between the perfusion/diffusion and diffusion/FLAIR mismatch: data from the AXIS2 trial. J Cereb Blood Flow Metab (2015) 0.78

DWI intensity values predict FLAIR lesions in acute ischemic stroke. PLoS One (2014) 0.78

Predicting intracerebral hemorrhage by baseline magnetic resonance imaging in stroke patients undergoing systemic thrombolysis. Acta Neurol Scand (2014) 0.78

The usefulness of diffusion-weighted/fluid-attenuated inversion recovery imaging in the diagnostics and timing of lacunar and nonlacunar stroke. Neuroradiology (2014) 0.78

Current concepts on magnetic resonance imaging (MRI) perfusion-diffusion assessment in acute ischaemic stroke: a review & an update for the clinicians. Indian J Med Res (2014) 0.76

Difficulty of MRI based identification of lesion age by acute infra-tentorial ischemic stroke. PLoS One (2014) 0.76

Modeling the Cost Effectiveness of Neuroimaging-Based Treatment of Acute Wake-Up Stroke. PLoS One (2016) 0.75

Diffusion-weighted imaging-fluid-attenuated inversion recovery mismatch is associated with better neurologic response to intravenous thrombolytic therapy in acute ischemic stroke patients. Clin Exp Emerg Med (2015) 0.75

Association Between Time From Stroke Onset and Fluid-Attenuated Inversion Recovery Lesion Intensity Is Modified by Status of Collateral Circulation. Stroke (2016) 0.75

Magnetic Resonance Imaging Protocol for Stroke Onset Time Estimation in Permanent Cerebral Ischemia. J Vis Exp (2017) 0.75

Distance to thrombus on MR angiography predicts outcome of middle cerebral artery occlusion treated with IV thrombolysis. Neuroradiology (2015) 0.75

Articles by these authors

Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. N Engl J Med (2006) 18.25

Endarterectomy versus stenting in patients with symptomatic severe carotid stenosis. N Engl J Med (2006) 12.90

One-year cardiovascular event rates in outpatients with atherothrombosis. JAMA (2007) 5.61

Fluoxetine for motor recovery after acute ischaemic stroke (FLAME): a randomised placebo-controlled trial. Lancet Neurol (2011) 5.60

Risk Factors for Aneurysm Recurrence: Response Radiology (2017) 5.28

International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis. JAMA (2006) 5.00

Endarterectomy Versus Angioplasty in Patients with Symptomatic Severe Carotid Stenosis (EVA-3S) trial: results up to 4 years from a randomised, multicentre trial. Lancet Neurol (2008) 4.12

Short-term outcome after stenting versus endarterectomy for symptomatic carotid stenosis: a preplanned meta-analysis of individual patient data. Lancet (2010) 4.07

Addition of brain and carotid imaging to the ABCD² score to identify patients at early risk of stroke after transient ischaemic attack: a multicentre observational study. Lancet Neurol (2010) 2.87

Rivaroxaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of ROCKET AF. Lancet Neurol (2012) 2.77

Sequential-design, multicenter, randomized, controlled trial of early decompressive craniectomy in malignant middle cerebral artery infarction (DECIMAL Trial). Stroke (2007) 2.62

Patients with prior myocardial infarction, stroke, or symptomatic peripheral arterial disease in the CHARISMA trial. J Am Coll Cardiol (2007) 2.56

Transesophageal echocardiography in cryptogenic stroke and patent foramen ovale: analysis of putative high-risk features from the risk of paradoxical embolism database. Circ Cardiovasc Imaging (2013) 2.56

Risk of myocardial infarction and vascular death after transient ischemic attack and ischemic stroke: a systematic review and meta-analysis. Stroke (2005) 2.38

European consensus on the diagnosis and management of fibromuscular dysplasia. J Hypertens (2014) 2.28

An index to identify stroke-related vs incidental patent foramen ovale in cryptogenic stroke. Neurology (2013) 2.26

Prevalence, clinical profile, and cardiovascular outcomes of atrial fibrillation patients with atherothrombosis. Am Heart J (2008) 2.09

Aortic stiffness measurement improves the prediction of asymptomatic coronary artery disease in stroke/transient ischemic attack patients. Int J Stroke (2013) 2.07

Comparative determinants of 4-year cardiovascular event rates in stable outpatients at risk of or with atherothrombosis. JAMA (2010) 1.97

Three-year follow-up and event rates in the international REduction of Atherothrombosis for Continued Health Registry. Eur Heart J (2009) 1.84

Trends in cardiovascular mortality in patients with rheumatoid arthritis over 50 years: a systematic review and meta-analysis of cohort studies. Rheumatology (Oxford) (2009) 1.79

Restenosis is more frequent after carotid stenting than after endarterectomy: the EVA-3S study. Stroke (2011) 1.72

Diffusion tensor imaging in early Alzheimer's disease. Psychiatry Res (2006) 1.62

Relationships between recent intraplaque hemorrhage and stroke risk factors in patients with carotid stenosis: the HIRISC study. Arterioscler Thromb Vasc Biol (2011) 1.61

Dynamic imaging response following radiation therapy predicts long-term outcomes for diffuse low-grade gliomas. Neuro Oncol (2012) 1.59

Aetiological diagnosis of ischaemic stroke in young adults. Lancet Neurol (2010) 1.58

Mechanical and structural characteristics of carotid plaques by combined analysis with echotracking system and MR imaging. JACC Cardiovasc Imaging (2011) 1.48

18F-FDG PET reveals frontotemporal dysfunction in children with fever-induced refractory epileptic encephalopathy. J Nucl Med (2010) 1.46

Characteristics and outcomes of patients with multiple cervical artery dissection. Stroke (2013) 1.46

Three-tesla functional MR language mapping: comparison with direct cortical stimulation in gliomas. Neurology (2015) 1.45

The REduction of Atherothrombosis for Continued Health (REACH) Registry: an international, prospective, observational investigation in subjects at risk for atherothrombotic events-study design. Am Heart J (2006) 1.45

Neuronal immunoexpression and a distinct subtype of adult primary supratentorial glioblastoma with a better prognosis. J Neurosurg (2012) 1.44

Stenting for carotid artery stenosis. Nat Clin Pract Neurol (2007) 1.44

DWI lesions and TIA etiology improve the prediction of stroke after TIA. Stroke (2008) 1.43

High risk of clinical cardiovascular events in rheumatoid arthritis: Levels of associations of myocardial infarction and stroke through a systematic review and meta-analysis. Arch Cardiovasc Dis (2010) 1.35

Addition of brain infarction to the ABCD2 Score (ABCD2I): a collaborative analysis of unpublished data on 4574 patients. Stroke (2010) 1.35

Reproducibility of high-resolution MRI for the identification and the quantification of carotid atherosclerotic plaque components: consequences for prognosis studies and therapeutic trials. Stroke (2007) 1.33

The risk of paradoxical embolism (RoPE) study: initial description of the completed database. Int J Stroke (2012) 1.32

Inclusion of stroke in cardiovascular risk prediction instruments: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke (2012) 1.28

Anatomical and technical factors associated with stroke or death during carotid angioplasty and stenting: results from the endarterectomy versus angioplasty in patients with symptomatic severe carotid stenosis (EVA-3S) trial and systematic review. Stroke (2010) 1.25

Subarachnoid hemorrhage as the initial presentation of dural sinus thrombosis. AJNR Am J Neuroradiol (2005) 1.25

Which MR-derived perfusion parameters are the best predictors of infarct growth in hyperacute stroke? Comparative study between relative and quantitative measurements. Radiology (2002) 1.21

Diffusion lesion reversal after thrombolysis: a MR correlate of early neurological improvement. Stroke (2012) 1.21

Prevalence of asymptomatic coronary artery disease in ischemic stroke patients: the PRECORIS study. Circulation (2010) 1.20

Evaluation of hyperintense vessels on FLAIR MRI for the diagnosis of multiple intracerebral arterial stenoses. Stroke (2003) 1.19

Spontaneous intracerebral hematoma on diffusion-weighted images: influence of T2-shine-through and T2-blackout effects. AJNR Am J Neuroradiol (2005) 1.17

Triggers of ischemic stroke: a systematic review. Stroke (2010) 1.16

Leigh-like encephalopathy complicating Leber's hereditary optic neuropathy. Ann Neurol (2002) 1.14

Cervical artery dissection: trauma and other potential mechanical trigger events. Neurology (2013) 1.12

Clot burden score on admission T2*-MRI predicts recanalization in acute stroke. Stroke (2013) 1.10

Safety of endovascular treatment of carotid artery stenosis compared with surgical treatment: a meta-analysis. J Vasc Surg (2008) 1.10

Carotid stenting: is there an operator effect? A pooled analysis from the carotid stenting trialists' collaboration. Stroke (2013) 1.07

Reversible angiopathy and encephalopathy after blood transfusion. J Neurol (2003) 1.06

The Essen stroke risk score predicts recurrent cardiovascular events: a validation within the REduction of Atherothrombosis for Continued Health (REACH) registry. Stroke (2008) 1.05

Skin involvement in Susac's syndrome. J Neurol Sci (2011) 1.04

Three-dimensional dynamic magnetic resonance angiography for the evaluation of radiosurgically treated cerebral arteriovenous malformations. Eur Radiol (2005) 1.03

An international model to predict recurrent cardiovascular disease. Am J Med (2012) 1.02

Magnetic Resonance Imaging-DRAGON score: 3-month outcome prediction after intravenous thrombolysis for anterior circulation stroke. Stroke (2013) 1.00

Endovascular treatment of intracranial unruptured aneurysms: a systematic review of the literature on safety with emphasis on subgroup analyses. Radiology (2012) 1.00

Effect of clopidogrel plus ASA vs. ASA early after TIA and ischaemic stroke: a substudy of the CHARISMA trial. Int J Stroke (2011) 1.00

Three-dimensional dynamic MR digital subtraction angiography using sensitivity encoding for the evaluation of intracranial arteriovenous malformations: a preliminary study. AJNR Am J Neuroradiol (2005) 0.99

Impact of tissue plasminogen activator on the neurovascular unit: from clinical data to experimental evidence. J Cereb Blood Flow Metab (2011) 0.99

Systematic review of the perioperative risks of stroke or death after carotid angioplasty and stenting. Stroke (2009) 0.98

Cerebral microembolism during cardiac catheterization and risk of acute brain injury: a prospective diffusion-weighted magnetic resonance imaging study. Stroke (2006) 0.97

The risk of carotid artery stenting compared with carotid endarterectomy is greatest in patients treated within 7 days of symptoms. J Vasc Surg (2012) 0.96

Risk factor profile and management of cerebrovascular patients in the REACH Registry. Cerebrovasc Dis (2008) 0.95

3T MRI improves the detection of transmantle sign in type 2 focal cortical dysplasia. Epilepsia (2013) 0.94

Dysembryoplastic neuroepithelial tumors: an MRI-based scheme for epilepsy surgery. Neurology (2012) 0.93

Can DWI-ASPECTS substitute for lesion volume in acute stroke? Stroke (2013) 0.93

Language lateralization in temporal lobe epilepsy using functional MRI and probabilistic tractography. Epilepsia (2008) 0.93

Fibromuscular dysplasia of cervical and intracranial arteries. Int J Stroke (2010) 0.92

High-resolution MR imaging of the cervical arterial wall: what the radiologist needs to know. Radiographics (2009) 0.91